Drug Type Small molecule drug |
Synonyms SFA006 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cytokine Release Syndrome | Preclinical | United States | 01 Mar 2022 | |
| Post Acute COVID 19 Syndrome | Preclinical | United States | 01 Mar 2022 | |
| Respiratory Distress Syndrome | Preclinical | United States | 01 Mar 2022 | |
| Sepsis | Preclinical | United States | 01 Mar 2022 |





